GWM
CNMD icon

Gilpin Wealth Management’s CONMED CNMD Stock Holding History

Gilpin Wealth Management’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$164 Sell
5
-10
-67% -$360 ﹤0.01% 957
2026
Q1 		$531 Buy
+15
New +$610 ﹤0.01% 594

Other funds holding CNMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $113B AUM 34.64% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return

Gilpin Wealth Management's CNMD Position: Q2 2026 in Review

Gilpin Wealth Management reduced its CONMED (CNMD) stake by 67% in Q2 2026, selling an estimated $360 and leaving 5 shares worth $164. The position accounts for ﹤0.01% of the portfolio, ranked #957.

Gilpin Wealth Management first reported a position in CNMD in Q1 2026 and has held it in 2 quarters since. The position peaked at $531 in Q1 2026. 246 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

  • Gilpin Wealth Management held 5 shares of CONMED worth $164 as of Q2 2026.
  • Gilpin Wealth Management sold 10 CONMED shares in Q2 2026, an estimated $360.
  • CONMED made up ﹤0.01% of Gilpin Wealth Management's portfolio in Q2 2026, its #957 holding.
  • Gilpin Wealth Management first reported a position in CONMED in Q1 2026 and has held it in 2 quarters since.
  • Gilpin Wealth Management's CONMED position peaked at $531 in Q1 2026.
  • 246 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on Gilpin Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.